<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39468199</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>29</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>A single-center analysis of clonal transmission of carbapenem-resistant Acinetobacter baumannii among intensive care unit patients during the COVID-19 pandemic.</ArticleTitle><Pagination><StartPage>25897</StartPage><MedlinePgn>25897</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-77238-4</ELocationID><Abstract><AbstractText>Carbapenem-Resistant Acinetobacter baumannii (CRAB) outbreak in intensive care units (ICUs) is a significant problem for healthcare facilities. In this study, we aimed to investigate the occurrence of CRAB isolates among ICU-admitted patients during the three waves of the COVID-19 pandemic in Iran using Multiple-Locus Variable Number Tandem-Repeat Analysis (MLVA). We obtained 50 (A) baumannii isolates from tracheal aspirate and blood culture samples. In the disc diffusion method, all isolates were cefotaxime, ceftriaxone, and cefepime-resistant, while 98% (49/50) of isolates were resistant to piperacillin, piperacillin-tazobactam, ceftazidime, and ciprofloxacin. Levofloxacin and tobramycin resistance was found in 76% (38/50) of isolates. In the microbroth dilution test all isolates were resistant to imipenem, 98% (49/50) to meropenem, 68% (34/50) to colistin, and 20% (10/50) to polymyxin (B) Based on the PCR findings, all isolates harbored bla<sub>OXA-40</sub>, ISAba-1, and int-2 genes. There were no isolates found that have the bla<sub>OXA-58</sub>, bla<sub>OXA-143</sub>, bla<sub>VEB-1</sub>, bla<sub>VIM</sub>, and int-3 genes. Among Extended-spectrum beta-lactamases (ESBL) genes, bla<sub>CTX-M</sub>, bla<sub>TEM</sub>, bla<sub>SHV</sub>, bla<sub>GES</sub>, and bla<sub>PER-1</sub> have a prevalence of 42% (21/50), 84% (42/50), 58% (29/50), 78% (39/50), and 54% (27/50), respectively. 74% (37/50) of the isolates had the bla<sub>OXA-23</sub> gene, while all of the isolates carried the bla<sub>OXA-40</sub> gene. Among MBL genes, bla<sub>IPM</sub>, bla<sub>GIM</sub>, bla<sub>SIM</sub>, and bla<sub>NDM-1</sub> have a prevalence of 20% (10/50), 8% (4/50), 22% (11/50), and 60% (30/50), respectively. The prevalence of int-1 was documented as 74% (37/50). Accordingly, all isolates were identified as CRAB. The co-existence of bla<sub>OXA-23</sub>/int-2 and bla<sub>OXA-23</sub>/isaba-1 was 74% (37/50). The co-existence of bla<sub>NDM-1</sub>/ISAba-1 was observed in 30 (60%) isolates. Using an 80% similarity threshold on the dendrogram constructed through MLVA typing, all isolates were grouped into two clusters: cluster A with 9 isolates from wave 3, and cluster B with 41 isolates from waves 3, 4, and 5. Our study confirms a clonal transmission of CRAB during the study period and suggests using molecular typing methods like MLVA in healthcare settings to identify dominant clones, antibiotic resistance patterns, and transmission routes. This will help to better manage the emergence and spread of antibiotic-resistant strains in future outbreaks.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Azimzadeh</LastName><ForeName>Masoud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Hamadan University of Medical Sciences, Hamadan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahador</LastName><ForeName>Abbas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shiralizadeh</LastName><ForeName>Somaye</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Hamadan University of Medical Sciences, Hamadan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahshouri</LastName><ForeName>Parisa</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Hamadan University of Medical Sciences, Hamadan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akbari</LastName><ForeName>Ladan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Hamadan University of Medical Sciences, Hamadan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makari</LastName><ForeName>Sama</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Hamadan University of Medical Sciences, Hamadan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rezaei</LastName><ForeName>Atefeh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Hamadan University of Medical Sciences, Hamadan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alikhani</LastName><ForeName>Mohammad Sina</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alikhani</LastName><ForeName>Mohammad Yousef</ForeName><Initials>MY</Initials><Identifier Source="ORCID">0000-0003-4577-4029</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Hamadan University of Medical Sciences, Hamadan, Iran. alikhani43@yahoo.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease Research Center, Avicenna Institute of Clinical Sciences, Hamadan University of Medical Sciences, Hamadan, IR, Iran. alikhani43@yahoo.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015780">Carbapenems</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.5.2.6</RegistryNumber><NameOfSubstance UI="D001618">beta-Lactamases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040981" MajorTopicYN="Y">Acinetobacter baumannii</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015780" MajorTopicYN="Y">Carbapenems</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000151" MajorTopicYN="Y">Acinetobacter Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="Y">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007492" MajorTopicYN="N" Type="Geographic">Iran</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024901" MajorTopicYN="N">Drug Resistance, Multiple, Bacterial</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001618" MajorTopicYN="N">beta-Lactamases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Carbapenem-Resistant Acinetobacter baumannii</Keyword><Keyword MajorTopicYN="N">Dendrogram</Keyword><Keyword MajorTopicYN="N">ESBL</Keyword><Keyword MajorTopicYN="N">MBL</Keyword><Keyword MajorTopicYN="N">MLVA</Keyword><Keyword MajorTopicYN="N">Minimum spanning tree</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>0</Hour><Minute>51</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39468199</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-77238-4</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-77238-4</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Saleh Ahmed, M., Abdulrahman, Z. F. A. &amp; Taha, Z. M. A. Risk factors of clonally related, multi, and extensively drug-resistant Acinetobacter baumannii in severely Ill COVID-19 patients. Can. J. Infect. Dis. Med. Microbiol. https://doi.org/10.1155/2023/3139270 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2023/3139270</ArticleId><ArticleId IdType="pubmed">36814503</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco, N. et al. Risk factors and outcomes associated with multidrug-resistant Acinetobacter baumannii upon intensive care unit admission. Antimicrob. Agents Chemother. https://doi.org/10.1128/aac.01631-17 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/aac.01631-17</ArticleId><ArticleId IdType="pubmed">30126958</ArticleId><ArticleId IdType="pmc">6201073</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung, J. Y. et al. Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect. Dis. 10, 1–11. https://doi.org/10.1186/1471-2334-10-228 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-10-228</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng, W.-H. et al. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii. Int. J. Infect. Dis. 14, e764–e769. https://doi.org/10.1016/j.ijid.2010.02.2254 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2010.02.2254</ArticleId><ArticleId IdType="pubmed">20646946</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Chetrit, E. et al. An intervention to control an ICU outbreak of carbapenem-resistant Acinetobacter baumannii: long-term impact for the ICU and hospital. Crit Care. 22, 1–10. https://doi.org/10.1186/s13054-018-2247-y (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-018-2247-y</ArticleId></ArticleIdList></Reference><Reference><Citation>C.f.D. Control, Prevention, CDC’s antibiotic resistance threats in the United States, 2019, Centers for Disease Control and Prevention, Atlanta, GA. (2019)</Citation></Reference><Reference><Citation>Viehman, J. A., Nguyen, M. H. &amp; Doi, Y. Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections. Drugs. 74, 1315–1333. https://doi.org/10.1007/s40265-014-0267-8 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40265-014-0267-8</ArticleId><ArticleId IdType="pubmed">25091170</ArticleId><ArticleId IdType="pmc">4258832</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannella, M. &amp; Viale, P. Treating carbapenem-resistant Acinetobacter baumannii infections. Lancet Infec.t Dis. https://doi.org/10.1016/S1473-3099(23)00203-7 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00203-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Genovese, C. et al. Molecular epidemiology of antimicrobial resistant microorganisms in the 21th century: a review of the literature. Acta bio-medica. 91, 256. https://doi.org/10.23750/abm.v91i2.9176 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.23750/abm.v91i2.9176</ArticleId><ArticleId IdType="pubmed">32420962</ArticleId><ArticleId IdType="pmc">7569612</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipworth, S. et al. Molecular epidemiology and antimicrobial resistance phenotype of paediatric bloodstream infections caused by Gram-negative bacteria. Commun. Med. 2, 101. https://doi.org/10.1038/s43856-022-00161-0 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43856-022-00161-0</ArticleId><ArticleId IdType="pubmed">35968045</ArticleId><ArticleId IdType="pmc">9372158</ArticleId></ArticleIdList></Reference><Reference><Citation>Benitez, A. J. et al. Multilocus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical isolates from 1962 to the present: a retrospective study. J. Clin. Microbiol. 50, 3620–3626. https://doi.org/10.1128/JCM.01755-12 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01755-12</ArticleId><ArticleId IdType="pubmed">22952264</ArticleId><ArticleId IdType="pmc">3486201</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahyot, S. et al. Multiple-locus variable number tandem repeat analysis (MLVA) and tandem repeat sequence typing (TRST), helpful tools for subtyping Staphylococcus lugdunensis. Sci. Rep. 8, 11669. https://doi.org/10.1038/s41598-018-30144-y (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-30144-y</ArticleId><ArticleId IdType="pubmed">30076395</ArticleId><ArticleId IdType="pmc">6076266</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, G. et al. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan China. J. Clin. Virol. 127, 104364. https://doi.org/10.1016/j.jcv.2020.104364 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104364</ArticleId><ArticleId IdType="pubmed">32311650</ArticleId><ArticleId IdType="pmc">7194884</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacobbe, D.R., Battaglini, D., Ball, L., Brunetti, I., Bruzzone, B., Codda, G., Crea, F., De Maria, A., Dentone, C., Di Biagio, A. Bloodstream infections in critically ill patients with COVID-19. 50: e13319, https://doi.org/10.1111/eci.13319 (2020).</Citation></Reference><Reference><Citation>Hudzicki, J. Kirby-Bauer disk diffusion susceptibility test protocol. ASM. 15, 55–63 (2009).</Citation></Reference><Reference><Citation>W.P.C.a.L.S.I. (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 31st ed. CLSI supplement M100. 2021.</Citation></Reference><Reference><Citation>Litake, G. M., Ghole, V. S., Niphadkar, K. B. &amp; Joshi, S. G. Phenotypic ESBL detection in Acinetobacter baumannii: A real challenge. Am. J. Infect. Dis. 11, 48. https://doi.org/10.3844/ajidsp.2015.48.53 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.3844/ajidsp.2015.48.53</ArticleId></ArticleIdList></Reference><Reference><Citation>W.P.C.a.L.S.I. (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 28th ed. 2018.</Citation></Reference><Reference><Citation>Wilson, K. Preparation of genomic DNA from bacteria. Curr. Protoc. Mol. Biol. 56, 241–245. https://doi.org/10.1002/0471142727.mb0204s56 (2001).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471142727.mb0204s56</ArticleId></ArticleIdList></Reference><Reference><Citation>Stepanović, S. et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS. 115, 891–899. https://doi.org/10.1111/j.1600-0463.2007.apm_630.x (2007).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0463.2007.apm_630.x</ArticleId><ArticleId IdType="pubmed">17696944</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourcel, C. et al. Identification of variable-number tandem-repeat (VNTR) sequences in Acinetobacter baumannii and interlaboratory validation of an optimized multiple-locus VNTR analysis typing scheme. J. Clin. Microbiol. 49, 539–548. https://doi.org/10.1128/jcm.02003-10 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.02003-10</ArticleId><ArticleId IdType="pubmed">21147956</ArticleId><ArticleId IdType="pmc">3043498</ArticleId></ArticleIdList></Reference><Reference><Citation>D. Mangioni, V. Fox, L. Chatenoud, M. Bolis, N. Bottino, L. Cariani, F. Gentiloni Silverj, C. Matinato, G. Monti, A. Muscatello, A. Teri, L. Terranova, A. Piatti, A. Gori, G. Grasselli, N. Stocchetti, C. Alteri, Genomic Characterization of Carbapenem-Resistant Acinetobacter baumannii (CRAB) in Mechanically Ventilated COVID-19 Patients and Impact of Infection Control Measures on Reducing CRAB Circulation during the Second Wave of the SARS-CoV-2 Pandemic in Milan, Italy. 11: e0020923, https://doi.org/10.1128/spectrum.00209-23 (2023).</Citation></Reference><Reference><Citation>Schlosser, B. et al. Risk factors for transmission of carbapenem-resistant Acinetobacter baumannii in outbreak situations: results of a case-control study. BMC Infect. Dis. 24, 120. https://doi.org/10.1186/s12879-024-09015-7 (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-024-09015-7</ArticleId><ArticleId IdType="pubmed">38263063</ArticleId><ArticleId IdType="pmc">10807151</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoja, S. et al. Genotyping of carbapenem resistant Acinetobacter baumannii isolated from tracheal tube discharge of hospitalized patients in intensive care units Ahvaz, Iran. Iran. J. Microbiol. 5, 315–322 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">25848498</ArticleId><ArticleId IdType="pmc">4385154</ArticleId></ArticleIdList></Reference><Reference><Citation>Krzyściak, P., Chmielarczyk, A., Pobiega, M., Romaniszyn, D. &amp; Wójkowska-Mach, J. Acinetobacter baumannii isolated from hospital-acquired infection: Biofilm production and drug susceptibility. APMIS. 125, 1017–1026. https://doi.org/10.1111/apm.12739 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apm.12739</ArticleId><ArticleId IdType="pubmed">28913903</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Pozo, J. L. Novel treatment dynamics for biofilm-related infections. Expert Rev. Anti-infect. Ther. 19, 1443–1456. https://doi.org/10.1080/14787210.2021.1917993 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2021.1917993</ArticleId><ArticleId IdType="pubmed">33857401</ArticleId></ArticleIdList></Reference><Reference><Citation>Peeters, E., Nelis, H. J. &amp; Coenye, T. Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J. Microbiol. Methods. 72, 157–165. https://doi.org/10.1016/j.mimet.2007.11.010 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mimet.2007.11.010</ArticleId><ArticleId IdType="pubmed">18155789</ArticleId></ArticleIdList></Reference><Reference><Citation>Stepanović, S. et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS. 115, 891–899. https://doi.org/10.1111/j.1600-0463.2007.apm_630.x (2007).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0463.2007.apm_630.x</ArticleId><ArticleId IdType="pubmed">17696944</ArticleId></ArticleIdList></Reference><Reference><Citation>Azeredo, J. et al. Critical review on biofilm methods. Crit. Rev. Microbiol. 43, 313–351. https://doi.org/10.1080/1040841x.2016.1208146 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1040841x.2016.1208146</ArticleId><ArticleId IdType="pubmed">27868469</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli, G. et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region Italy. JAMA. 323, 1574–1581. https://doi.org/10.1001/jama.2020.5394 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.5394</ArticleId><ArticleId IdType="pubmed">32250385</ArticleId><ArticleId IdType="pmc">7136855</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi, Y. et al. Predicting recurrence of respiratory failure in critically ill patients with COVID-19: A preliminary study. J. Infect. 82, e33–e35. https://doi.org/10.1016/j.jinf.2021.01.016 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.016</ArticleId><ArticleId IdType="pubmed">33503468</ArticleId><ArticleId IdType="pmc">7830219</ArticleId></ArticleIdList></Reference><Reference><Citation>Jazani, N., Babazadeh, H., Sohrabpour, M., Zartoshti, M. &amp; Ghasemi Rad, M. The prevalence of extended spectrum beta-lactamases in Acinetobacter baumannii isolates from burn wounds in Iran. Internet J. Microbiol. 9, 1–7 (2011).</Citation></Reference><Reference><Citation>Bhattacharjee, A., Sen, M., Prakash, P., Gaur, A. &amp; Anupurba, S. Increased prevalence of extended spectrum βlactamase producers in neonatal septicaemic cases at a tertiary referral hospital. Indian J. Med. Microbiol. 26, 356–360 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0255-0857(21)01814-4</ArticleId><ArticleId IdType="pubmed">18974490</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha, M., Srinivasa, H. &amp; Macaden, R. Antibiotic resistance profile &amp; extended spectrum beta-lactamase (ESBL) production in Acinetobacter species. Indian J. Med. Res. 126, 63–67 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17890826</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashemizadeh, Z., Emami, A. &amp; Rahimi, M. Acinetobacter antibiotic resistance and frequency of ESBL-producing strains in ICU patients of Namazi Hospital (2008–2009). J. Inflam. Dis. 14, 47–53 (2010).</Citation></Reference><Reference><Citation>Singla, P., Sikka, R., Deeep, A., Gagneja, D. &amp; Chaudhary, U. Co-production of ESBL and AmpC β-lactamases in Clinical isolates of A. baumannii and A. lwoffii in a tertiary care hospital from Northern India. J. Clin. Diagnos. Res. JCDR. 8, 16. https://doi.org/10.7860/JCDR/2014/8008.4289 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.7860/JCDR/2014/8008.4289</ArticleId></ArticleIdList></Reference><Reference><Citation>Kansal, R., Pandey, A. &amp; Asthana, A. K. β-lactamase producing Acinetobacter species in hospitalized patients. Indian J. Pathol. Microbiol. 52, 456–457. https://doi.org/10.4103/0377-4929.55035 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0377-4929.55035</ArticleId><ArticleId IdType="pubmed">19680002</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Sheboul, S. A. et al. Molecular characterization of carbapenem-resistant Acinetobacter baumannii isolated from intensive care unit patients in Jordanian hospitals. Antibiotics. 11, 835. https://doi.org/10.3390/antibiotics11070835 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics11070835</ArticleId><ArticleId IdType="pubmed">35884089</ArticleId><ArticleId IdType="pmc">9311868</ArticleId></ArticleIdList></Reference><Reference><Citation>Farajnia, S. et al. Prevalence of PER and VEB type extended spectrum betalactamases among multidrug resistant Acinetobacter baumannii isolates in North-West of Iran. Iran. J. Basic Med. Sci. 16, 751 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23997900</ArticleId><ArticleId IdType="pmc">3758029</ArticleId></ArticleIdList></Reference><Reference><Citation>Alyamani, E. J. et al. Molecular characterization of extended-spectrum beta-lactamases (ESBLs) produced by clinical isolates of Acinetobacter baumannii in Saudi Arabia. Ann. Clin. Microbiol. Antimicrob. 14, 1–9. https://doi.org/10.1186/s12941-015-0098-9 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12941-015-0098-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Colquhoun, J. M. et al. OXA-23 β-lactamase overexpression in Acinetobacter baumannii drives physiological changes resulting in new genetic vulnerabilities. MBio. 12, e03137-e3221. https://doi.org/10.1128/mBio.03137-21 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.03137-21</ArticleId><ArticleId IdType="pubmed">34872351</ArticleId><ArticleId IdType="pmc">8649759</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown, S. &amp; Amyes, S. OXA β-lactamases in Acinetobacter: The story so far. J. Antimicrob. Chemother. 57, 1–3. https://doi.org/10.1093/jac/dki425 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dki425</ArticleId><ArticleId IdType="pubmed">16332731</ArticleId></ArticleIdList></Reference><Reference><Citation>Principe, L. et al. Epidemic diffusion of OXA-23-producing Acinetobacter baumannii isolates in Italy: Results of the first cross-sectional countrywide survey. J. Clin. Microbiol. 52, 3004–3010. https://doi.org/10.1128/JCM.00291-14 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00291-14</ArticleId><ArticleId IdType="pubmed">24920776</ArticleId><ArticleId IdType="pmc">4136168</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Atrouni, A. et al. Wide spread of OXA-23-producing carbapenem-resistant Acinetobacter baumannii belonging to clonal complex II in different hospitals in Lebanon. Int. J. Infect. Dis. 52, 29–36. https://doi.org/10.1016/j.ijid.2016.09.017 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2016.09.017</ArticleId><ArticleId IdType="pubmed">27663910</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuertz, K. F. et al. Bacteremia and meningitis caused by OXA-23-producing Acinetobacter baumannii–molecular characterization and susceptibility testing for alternative antibiotics, Braz. J Microbiol. 49, 199–204. https://doi.org/10.1016/j.bjm.2018.04.002 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjm.2018.04.002</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva, K. E. et al. A high mortality rate associated with multidrug-resistant Acinetobacter baumannii ST79 and ST25 carrying OXA-23 in a Brazilian intensive care unit. PloS one. 13, e0209367. https://doi.org/10.1371/journal.pone.0209367 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0209367</ArticleId><ArticleId IdType="pubmed">30592758</ArticleId><ArticleId IdType="pmc">6310363</ArticleId></ArticleIdList></Reference><Reference><Citation>Turton, J. F. et al. The role of IS Aba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol. Lett. 258, 72–77. https://doi.org/10.1111/j.1574-6968.2006.00195.x (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6968.2006.00195.x</ArticleId><ArticleId IdType="pubmed">16630258</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi, P. R. et al. Co-existence of bla OXA-23 and bla NDM-1 genes of Acinetobacter baumannii isolated from Nepal: Antimicrobial resistance and clinical significance. Antimicrob. Resist. Infect. Control. 6, 1–7. https://doi.org/10.1186/s13756-017-0180-5 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13756-017-0180-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, Z.-Y. et al. Co-existence of bla OXA-23 and bla VIM in carbapenem-resistant Acinetobacter baumannii isolates belonging to global complex 2 in a Chinese teaching hospital. Chin. Med. J. 132, 1166–1172. https://doi.org/10.1097/CM9.0000000000000193 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000000193</ArticleId><ArticleId IdType="pubmed">30882466</ArticleId><ArticleId IdType="pmc">6511418</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee, S. et al. Carbapenem resistance in Acinetobacter baumannii and other Acinetobacter spp. causing neonatal sepsis: focus on NDM-1 and its linkage to IS Aba125. Front. Microbiol. 7, 1126. https://doi.org/10.3389/fmicb.2016.01126 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.01126</ArticleId><ArticleId IdType="pubmed">27551277</ArticleId><ArticleId IdType="pmc">4976090</ArticleId></ArticleIdList></Reference><Reference><Citation>N.S. Fam, D. Gamal, S.H. Mohamed, R.M. Wasfy, M.S. Soliman, A.A. El-Kholy, P.G. Higgins, Molecular characterization of Carbapenem/Colistin-resistant Acinetobacter baumannii clinical isolates from Egypt by whole-genome sequencing, Infection and Drug Resistance. (2020) 4487–93,</Citation></Reference><Reference><Citation>Vakili, B. et al. Detection of colistin sensitivity in clinical isolates of Acinetobacter baumannii in Iran. J. Res. Med. Sci. J. Isfahan Univ. Med. Sci. 19, S67 (2014).</Citation></Reference><Reference><Citation>Ezadi, F., Jamali, A., Heidari, A., Javid, N. &amp; Ardebili, A. Heteroresistance to colistin in oxacillinase-producing carbapenem-resistant Acinetobacter baumannii clinical isolates from Gorgan, Northern Iran. J. Glob. Antimicrob. Resist. 21, 380–385. https://doi.org/10.1016/j.jgar.2019.11.010 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jgar.2019.11.010</ArticleId><ArticleId IdType="pubmed">31770604</ArticleId></ArticleIdList></Reference><Reference><Citation>Seleim, S. M., Mostafa, M. S., Ouda, N. H. &amp; Shash, R. Y. The role of pmrCAB genes in colistin-resistant Acinetobacter baumannii. Sci. Rep. 12, 20951. https://doi.org/10.1038/s41598-022-25226-x (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-25226-x</ArticleId><ArticleId IdType="pubmed">36470921</ArticleId><ArticleId IdType="pmc">9722906</ArticleId></ArticleIdList></Reference><Reference><Citation>Hameed, F. et al. Plasmid-mediated mcr-1 gene in Acinetobacter baumannii and Pseudomonas aeruginosa: first report from Pakistan. Rev. Soc. Bras. Med. Trop. 52, e20190237. https://doi.org/10.1590/0037-8682-0237-2019 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0037-8682-0237-2019</ArticleId><ArticleId IdType="pubmed">31508785</ArticleId></ArticleIdList></Reference><Reference><Citation>Wistrand-Yuen, P. et al. Evaluation of polymyxin B in combination with 13 other antibiotics against carbapenemase-producing Klebsiella pneumoniae in time-lapse microscopy and time-kill experiments. Clin. Microbiol. Infect. 26, 1214–1221. https://doi.org/10.1016/j.cmi.2020.03.007 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.03.007</ArticleId><ArticleId IdType="pubmed">32224200</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghazalibina, M. et al. Prevalence of integrons and antibiotic resistance pattern in Acinetobacter baumannii isolated from clinical samples of Iranian patients: A systematic review and meta-analysis. Ethiop. J. Health Sci. https://doi.org/10.4314/ejhs.v29i5.15 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.4314/ejhs.v29i5.15</ArticleId><ArticleId IdType="pubmed">31666786</ArticleId><ArticleId IdType="pmc">6813273</ArticleId></ArticleIdList></Reference><Reference><Citation>Halaji, M., Rezaei, A., Zalipoor, M. &amp; Faghri, J. Investigation of class I II, and III integrons among Acinetobacter baumannii isolates from hospitalized patients in Isfahan, Iran, Oman. Med. J. 33, 37. https://doi.org/10.5001/omj.2018.07 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.5001/omj.2018.07</ArticleId></ArticleIdList></Reference><Reference><Citation>Maciel, W. et al. Clonal spread of carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit. J. Hosp. Infect. 98, 300–304. https://doi.org/10.1016/j.jhin.2017.10.015 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2017.10.015</ArticleId><ArticleId IdType="pubmed">29107079</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying, C., Li, Y., Wang, Y., Zheng, B. &amp; Yang, C. Investigation of the molecular epidemiology of Acinetobacter baumannii isolated from patients and environmental contamination. J. Antibiot. 68, 562–567. https://doi.org/10.1038/ja.2015.30 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ja.2015.30</ArticleId></ArticleIdList></Reference><Reference><Citation>Boral, J. et al. The association between Acinetobacter baumannii infections and the COVID-19 pandemic in an intensive care unit. Sci. Rep. 12, 20808. https://doi.org/10.1038/s41598-022-25493-8 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-25493-8</ArticleId><ArticleId IdType="pubmed">36460749</ArticleId><ArticleId IdType="pmc">9716169</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahy, S., O’Connor, J., Lucey, B. &amp; Sleator, R. Hospital reservoirs of multidrug resistant acinetobacter species—the elephant in the room!. Br. J. Biomed. Sci. 80, 11098. https://doi.org/10.3389/bjbs.2023.11098 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/bjbs.2023.11098</ArticleId><ArticleId IdType="pubmed">37020476</ArticleId><ArticleId IdType="pmc">10069268</ArticleId></ArticleIdList></Reference><Reference><Citation>Adewoyin, M. A. &amp; Okoh, A. I. The natural environment as a reservoir of pathogenic and non-pathogenic Acinetobacter species. Rev. Environ. Health. 33, 265–272. https://doi.org/10.1515/reveh-2017-0034 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/reveh-2017-0034</ArticleId><ArticleId IdType="pubmed">29982240</ArticleId></ArticleIdList></Reference><Reference><Citation>Bali, E. B., Acik, L. &amp; Sultan, N. Phenotypic and molecular characterization of SHV, TEM, CTX-M and extended-spectrum beta-lactamase produced by Escherichia coli, Acinobacter baumannii and Klebsiella isolates in a Turkish hospital, Afr. J. Microbiol. Res. 4, 650–654 (2010).</Citation></Reference><Reference><Citation>Lal, P., Kapil, A., Das, B. K. &amp; Sood, S. Occurrence of TEM &amp; SHV gene in extended spectrum β-lactamases (ESBLs) producing Klebsiella sp. isolated from a tertiary care hospital. Indian J. Med. Res. 125, 173–178 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17431288</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiratisin, P., Apisarnthanarak, A., Laesripa, C. &amp; Saifon, P. Molecular characterization and epidemiology of extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob. Agents Chemother. 52, 2818–2824. https://doi.org/10.1128/aac.00171-08 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/aac.00171-08</ArticleId><ArticleId IdType="pubmed">18505851</ArticleId><ArticleId IdType="pmc">2493136</ArticleId></ArticleIdList></Reference><Reference><Citation>Poirel, L. et al. Extended-spectrum β-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in France. J. Antimicrob. Chemother. 43, 157–158. https://doi.org/10.1093/jac/43.1.157 (1999).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/43.1.157</ArticleId><ArticleId IdType="pubmed">10381117</ArticleId></ArticleIdList></Reference><Reference><Citation>Zafer, M. M., Al-Agamy, M. H., El-Mahallawy, H. A., Amin, M. A. &amp; Ashour, M.S.E.-D. Antimicrobial resistance pattern and their beta-lactamase encoding genes among Pseudomonas aeruginosa strains isolated from cancer patients. Biomed. Res. Int. https://doi.org/10.1155/2014/101635 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/101635</ArticleId><ArticleId IdType="pubmed">24707471</ArticleId><ArticleId IdType="pmc">3953503</ArticleId></ArticleIdList></Reference><Reference><Citation>Khorsi, K., Messai, Y., Hamidi, M., Ammari, H. &amp; Bakour, R. High prevalence of multidrug-resistance in Acinetobacter baumannii and dissemination of carbapenemase-encoding genes blaOXA-23-like, blaOXA-24-like and blaNDM-1 in Algiers hospitals. Asian Pac. J. Trop. Med. 8, 438–446. https://doi.org/10.1016/j.apjtm.2015.05.011 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apjtm.2015.05.011</ArticleId><ArticleId IdType="pubmed">26194827</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobs, V. C. et al. The role of the genetic elements bla oxa and IS Aba 1 in the Acinetobacter calcoaceticus-Acinetobacter baumannii complex in carbapenem resistance in the hospital setting. Rev. Soc. Bras. Med. Trop. 49, 433–440. https://doi.org/10.1590/0037-8682-0002-2016 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0037-8682-0002-2016</ArticleId><ArticleId IdType="pubmed">27598629</ArticleId></ArticleIdList></Reference><Reference><Citation>Amudhan, S., Sekar, U., Arunagiri, K. &amp; Sekar, B. OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii. Indian J. Med. Microbiol. 29, 269–274. https://doi.org/10.4103/0255-0857.83911 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0255-0857.83911</ArticleId><ArticleId IdType="pubmed">21860108</ArticleId></ArticleIdList></Reference><Reference><Citation>Handal, R. et al. Characterization of carbapenem-resistant Acinetobacter baumannii strains isolated from hospitalized patients in Palestine. Int. J. Microbiol. https://doi.org/10.1155/2017/8012104 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/8012104</ArticleId><ArticleId IdType="pubmed">28814955</ArticleId><ArticleId IdType="pmc">5549501</ArticleId></ArticleIdList></Reference><Reference><Citation>Hujer, K. M. et al. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob. Agents Chemother. 50, 4114–4123. https://doi.org/10.1128/aac.00778-06 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/aac.00778-06</ArticleId><ArticleId IdType="pubmed">17000742</ArticleId><ArticleId IdType="pmc">1694013</ArticleId></ArticleIdList></Reference><Reference><Citation>Poirel, L., Walsh, T. R., Cuvillier, V. &amp; Nordmann, P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 70, 119–123. https://doi.org/10.1016/j.diagmicrobio.2010.12.002 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2010.12.002</ArticleId><ArticleId IdType="pubmed">21398074</ArticleId></ArticleIdList></Reference><Reference><Citation>Koeleman, J. G., Stoof, J., Van Der Bijl, M. W., Vandenbroucke-Grauls, C. M. &amp; Savelkoul, P. H. Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR. J. Clin. Microbiol. 39, 8–13. https://doi.org/10.1128/jcm.39.1.8-13.2001 (2001).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.39.1.8-13.2001</ArticleId><ArticleId IdType="pubmed">11136740</ArticleId><ArticleId IdType="pmc">87671</ArticleId></ArticleIdList></Reference><Reference><Citation>Ploy, M.-C.C., Denis, F. O., Courvalin, P. &amp; Lambert, T. Molecular characterization of integrons in Acinetobacter baumannii: description of a hybrid class 2 integron. Antimicrob. Agents Chemother. 44, 2684–2648. https://doi.org/10.1128/aac.44.10.2684-2688.2000 (2000).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/aac.44.10.2684-2688.2000</ArticleId><ArticleId IdType="pubmed">10991844</ArticleId><ArticleId IdType="pmc">90135</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>